Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib

AIM: To identify clinical biomarkers that could early predict improved survival in patients with advanced-stage hepatocellular carcinoma (HCC) treated with transarterial chemoembolization combined with sorafenib (TACE-S). METHODS: We retrospectively evaluated the medical records of consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiao-Chun, Chen, Bing-Hui, Huang, Jing-Jun, Huang, Wen-Sou, Cai, Ming-Yue, Zhou, Jing-Wen, Guo, Yong-Jian, Zhu, Kang-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787783/
https://www.ncbi.nlm.nih.gov/pubmed/29398869
http://dx.doi.org/10.3748/wjg.v24.i4.484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787783/
https://www.ncbi.nlm.nih.gov/pubmed/29398869
http://dx.doi.org/10.3748/wjg.v24.i4.484

Ejemplares similares